Desmopressin to prevent bleeding during kidney biopsy
Treatments studied
Part of Blood & lymphatic, Kidney & urinary clinical trials.
This trial tests if desmopressin can lower bleeding risk during a kidney transplant biopsy. It may help patients with reduced kidney function who need a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a kidney transplant and need a biopsy of the new kidney
- Your kidney function is below a certain level (GFR less than 60)
- Your platelet count is above 80,000
- Your blood pressure is under control before the procedure
- Your blood clotting tests are normal
- You are not pregnant and have no history of allergic reaction to DDAVP
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether desmopressin can make kidney biopsy safer by reducing bleeding risk. It compares safety outcomes after a biopsy in people who meet specific blood, medication, and health criteria.
This trial tests two medications, tranexamic acid and desmopressin, to see if they can reduce bleeding during surgery in people with severe kidney disease or on dialysis. The results may help make surgery safer for you.
This study looks at how common diabetic kidney damage is in people with type 2 diabetes, and which factors can predict it. If you qualify, you may be asked to have a kidney biopsy to understand what’s happening inside your kidneys.
This study tests whether a medicine called desmopressin (DDAVP) can reduce bleeding during heart surgery. It uses a special blood test (TEG6) to decide who gets the medicine.
This trial tests if a drug called desmopressin can reduce the need for blood transfusions during heart surgery. It is for people at high risk of bleeding, for example because they take blood thinners, have a clotting problem, or need a repeat heart surgery.
This trial tests if a drug called dipyridamole can prevent low phosphate levels after a kidney transplant. It is for adult kidney transplant patients who can safely take the drug.
Hear when a new Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.